ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.84% | 9.54% | 9.38% | 9.88% | 10.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.84% | 9.54% | 9.38% | 9.88% | 10.95% |
| Cost of Revenue | 3.12% | 2.34% | 1.55% | 3.95% | 8.72% |
| Gross Profit | 14.84% | 15.08% | 15.58% | 14.56% | 12.67% |
| SG&A Expenses | 8.06% | 5.73% | 4.21% | 3.27% | 4.85% |
| Depreciation & Amortization | -2.64% | -6.93% | -7.79% | -2.90% | 9.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.78% | 3.47% | 2.36% | 3.57% | 7.47% |
| Operating Income | 21.91% | 25.05% | 28.40% | 27.30% | 20.23% |
| Income Before Tax | 32.64% | 33.23% | 39.82% | 23.74% | 14.81% |
| Income Tax Expenses | 13.53% | 17.07% | 38.00% | 28.05% | 19.47% |
| Earnings from Continuing Operations | 37.20% | 37.03% | 40.24% | 22.77% | 13.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.20% | 37.03% | 40.24% | 22.77% | 13.75% |
| EBIT | 21.91% | 25.05% | 28.40% | 27.30% | 20.23% |
| EBITDA | 21.31% | 22.43% | 25.15% | 24.46% | 18.75% |
| EPS Basic | 37.48% | 37.23% | 40.38% | 22.74% | 13.57% |
| Normalized Basic EPS | 27.03% | 30.43% | 33.88% | 31.45% | 22.00% |
| EPS Diluted | 37.26% | 36.88% | 40.01% | 22.54% | 13.59% |
| Normalized Diluted EPS | 26.93% | 30.27% | 33.73% | 31.41% | 22.09% |
| Average Basic Shares Outstanding | -0.21% | -0.15% | -0.10% | 0.03% | 0.17% |
| Average Diluted Shares Outstanding | -0.11% | -0.03% | 0.01% | 0.05% | 0.09% |
| Dividend Per Share | 10.42% | 10.11% | 9.78% | 9.44% | 9.09% |
| Payout Ratio | -0.20% | -0.20% | -0.22% | -0.11% | -0.04% |